(1038–1054) Health Services Research Poster II

Monday, October 27, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

CAR-T Therapy in Rheumatoid Arthritis: A Health Systems Analysis of Cost and Global Equity
Abstract Poster Presenter: Asrith Reddy Gandu, MBBS – Davao Medical School Foundation
10:30 AM - 12:30 PM Central Time

Provider Characteristics and Beliefs and Patient Factors Associated with Long-term Glucocorticoid Use in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Michael George, MD, MSc – University of Pennsylvania
10:30 AM - 12:30 PM Central Time

Real-World Immunosuppressant Treatment Patterns in Lupus Nephritis: A Retrospective Claims Database Analysis in the United States
Abstract Poster Presenter: Anisha Patel, PhD – Genentech Inc.
10:30 AM - 12:30 PM Central Time

Bridging the Gap: A Mixed-Methods Study to Enhance Integration of HCQ-SAFE, A Shared Decision-Making Tool for Hydroxychloroquine Use, in Routine Lupus Care
Abstract Poster Presenter: Shivani Garg, MD, PhD – University of Madison, School of Medicine and Public Health
10:30 AM - 12:30 PM Central Time

Mitigating Hydroxychloroquine (HCQ) Nonadherence by Clarifying Misbeliefs Using a Shared Decision-Making Tool (HCQ-SAFE©) Across Two Different Rheumatology Centers
Abstract Poster Presenter: Shivani Garg, MD, PhD – University of Madison, School of Medicine and Public Health
10:30 AM - 12:30 PM Central Time

“prednisone… a Necessary Evil…” Developing an Evidence-based Benefits vs. Harms Shared Decision-making Tool (PRED-SAFE) to Support Decisions Around Chronic Prednisone Use
Abstract Poster Presenter: Shivani Garg, MD, PhD – University of Madison, School of Medicine and Public Health
10:30 AM - 12:30 PM Central Time

Cannabis Knowledge, Attitudes, and Practices Among Rheumatology Providers: Implications for Clinical Care and Education
Abstract Poster Presenter: Joanna Zeiger, PhD, MS – Canna Research Foundation
10:30 AM - 12:30 PM Central Time

Analysis of Medicare and Medicaid Utilization and Expenditure of Newly Approved Biologics for Systemic Lupus Erythematosus Patients in the United States
Abstract Poster Presenter: Gunjan Rana, MD (she/her/hers) – Saint Vincent Hospital
10:30 AM - 12:30 PM Central Time

Trends in Cost and Utilization of Biologic Medications for Rheumatologic Conditions: A Medicare Claims Study (2013–2022)
Abstract Poster Presenter: Taylor Koenig, MD – Cleveland Clinic
10:30 AM - 12:30 PM Central Time

Impact of Hydroxychloroquine Usage on QTc in Veterans with Rheumatic Musculoskeletal Disease
Abstract Poster Presenter: Malika Ibrahim, MD, MRCP – UCLA
10:30 AM - 12:30 PM Central Time

Impact of Clinical Pharmacist-Directed Patient Education on Medication Adherence and Clinical Outcomes in Patients with Inflammatory Arthritis
Abstract Poster Presenter: Cristina Hurley, MD (she/her/hers) – Virginia Tech Carilion SOM, Carilion Clinic
10:30 AM - 12:30 PM Central Time

The Care Pathway and Treatment Patterns in Patients with Uncontrolled Gout: A Real-World Survey of Physicians In The United States
Abstract Poster Presenter: Gordon Lam, MD, FACR – Arthritis & Osteoporosis Consultants of the Carolinas
10:30 AM - 12:30 PM Central Time

Primary Care Perspectives on Giant Cell Arteritis: Diagnostic Considerations, Referral Challenges, and Opportunities for Fast-Track Pathways in the U.S.
Abstract Poster Presenter: Jon Golenbiewski, DO – Wake Forest University School of Medicine
10:30 AM - 12:30 PM Central Time

Associated Factors and Direct Cost Analysis of Dose Reduction and Discontinuation of Biological Therapies in Rheumatoid Arthritis and Spondyloarthritis: Findings from a Colombian Cohort Within the Framework of an Integrated Management Model
Abstract Poster Presenter: Edwin Jauregui, MD – Riesgo de fractura S.A
10:30 AM - 12:30 PM Central Time

Biosimilar adalimumab prescriptions increase before the CVS formulary change and decrease after
Abstract Poster Presenter: Eric Roberts, PhD, MPH – University of California, San Francisco